Your browser doesn't support javascript.
loading
The role of RNA binding proteins in hepatocellular carcinoma.
Zhang, Kai; Barry, Anna E; Lamm, Ryan; Patel, Keyur; Schafer, Michelle; Dang, Hien.
Afiliação
  • Zhang K; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States; Sidney Kimmel Cancer Center, Philadelphia, PA, United States.
  • Barry AE; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States; Sidney Kimmel Cancer Center, Philadelphia, PA, United States.
  • Lamm R; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States.
  • Patel K; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States.
  • Schafer M; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States.
  • Dang H; Department of Surgery, Thomas Jefferson University, Philadelphia, PA, United States; Sidney Kimmel Cancer Center, Philadelphia, PA, United States. Electronic address: Hien.Dang@jefferson.edu.
Adv Drug Deliv Rev ; 182: 114114, 2022 03.
Article em En | MEDLINE | ID: mdl-35063534
Hepatocellular carcinoma (HCC) is one of the leading causes of overall cancer deaths worldwide with limited therapeutic options. Due to the heterogeneity of HCC pathogenesis, the molecular mechanisms underlying HCC development are not fully understood. Emerging evidence indicates that RNA-binding proteins (RBPs) play a vital role throughout hepatocarcinogenesis. Thus, a deeper understanding of how RBPs contribute to HCC progression will provide new tools for early diagnosis and prognosis of this devastating disease. In this review, we summarize the tumor suppressive and oncogenic roles of RBPs and their roles in hepatocarcinogenesis. The diagnostic and therapeutic potential of RBPs in HCC, including their limitations, are also discussed.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Ligação a RNA / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Ligação a RNA / Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Adv Drug Deliv Rev Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos